Figure 2.

Rituximab in rheumatoid arthritis. Phase IIa: changes in total rheumatoid factor (median). CTX, cyclophosphamide; MTX, methotrexate; RTX, rituximab. Data from Edwards and coworkers [5] and from Emery and coworkers [6].

Keystone Arthritis Research & Therapy 2005 7(Suppl 3):S13   doi:10.1186/ar1738